Magnify Biosciences is a technology company.
Magnify Biosciences has raised $100K across 1 funding round.
Magnify Biosciences has raised $100K in total across 1 funding round.
Magnify Biosciences is a biotechnology company that develops advanced 3D nano-imaging solutions based on expansion microscopy technology. Their flagship product, the Magnify™ Kit, enables researchers and clinicians to visualize biological samples at nanoscale resolution by physically expanding specimens up to 11-fold, allowing detailed analysis of cells, proteins, and other biomolecules with standard light microscopes. This technology serves a broad range of customers including over 150 research institutes, biotech, and biopharma companies, accelerating pre-clinical drug development, disease research, and diagnostics by making super-resolution imaging more accessible and user-friendly[1][2][4].
The company addresses the challenge of nanoscale biological imaging, which traditionally requires expensive and complex equipment, by providing a streamlined, cost-effective, and easy-to-use solution that preserves molecular details and enables high-plex imaging. Their interactive, real-time nanoimaging sessions further enhance the user experience by allowing direct collaboration between researchers and Magnify’s experts, facilitating faster and more informed scientific decisions[2][3].
Magnify Biosciences was founded by Yongxin (Leon) Zhao, who serves as the Chief Scientific Officer. The company emerged from a vision to democratize nanoscale imaging by simplifying expansion microscopy workflows, making them accessible to both expert and novice users. The idea was to create a robust, reproducible, and scalable sample preparation kit that could expand biological specimens isotropically while retaining critical biomolecules such as proteins, nucleic acids, and lipids[1][3].
Early traction included recognition in *Nature*, a leading scientific journal, which highlighted Magnify’s innovative approach to expansion microscopy and its potential to revolutionize biological discovery and diagnostics. This milestone validated their technology’s impact and helped establish credibility within the scientific community[3].
Magnify Biosciences rides the wave of increasing demand for precision medicine and advanced biological imaging technologies. The timing is critical as researchers seek scalable, cost-effective tools to explore molecular and structural changes in diseases at unprecedented resolution without relying on prohibitively expensive electron microscopes or super-resolution systems. Market forces such as the growth of biotech R&D, the need for better diagnostic tools, and the push for personalized medicine favor Magnify’s expansion microscopy platform[4].
By lowering barriers to nanoscale imaging, Magnify influences the broader ecosystem by enabling new discoveries in basic research, accelerating drug development pipelines, and fostering innovation in diagnostics. Their technology parallels transformative advances seen in genomics with next-generation sequencing, promising to create a significant impact on healthcare and biomedical research[4].
Looking ahead, Magnify Biosciences aims to expand multiplexing capabilities and automate their imaging workflows with devices like Auto-Magnify, which will further enhance accessibility and throughput for advanced brain research and other applications. Trends such as increasing demand for high-plex molecular imaging, AI-driven data analysis, and integrated diagnostics will shape their growth trajectory.
Their influence is likely to grow as they continue democratizing nanoscale imaging, enabling a wider range of scientists to visualize the unseen and accelerate breakthroughs in disease understanding and treatment development. Magnify Biosciences stands poised to be a key player in the future of precision medicine and biological discovery[4][5].
Magnify Biosciences has raised $100K in total across 1 funding round.
Magnify Biosciences's investors include Innovation Works.
Magnify Biosciences has raised $100K across 1 funding round. Most recently, it raised $100K Seed in December 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2023 | $100K Seed | Innovation Works |